Gapping up
In reaction to earnings/guidance:
- SIG +7.4%, AA +2.2%, AAL +1.4%, KMI +0.9%, BKR +0.8%, FITB +0.7%, SNV +0.7%, WNS +0.5%, KEY +0.5%
Other news:
- MCRB +9% (announced publication of data from Phase 3 ECOSPOR III study in the NEJM)
- PAYA +5.9% (announced acquisition of acquisition of VelocIT Business Solutions)
- ASTS +3.1% (discloses that launch provider now has confirmed a launch window in Summer 2022)
- CDXC +2.5% (announced a supply agreement with Designs for Health a U.S.-based manufacturer of premium dietary supplements for healthcare practitioners )
- ARGX +2.3% (receives approval of VYVGART in Japan)
- ENTG +2.1% (increases quarterly cash dividend to $0.10/share from $0.08/share)
- HUT +2% (acquires the cloud and data center business from TeraGo)
- AADI +1.8% (entered into certain negotiated purchase order terms and conditions for clinical and commercial product with Fresenius Kabi)
- NVAX +1.7% (receives provisional registration for COVID-19 Vaccine from Australia's TGA)
- KNTE +1.2% (to present preclinical data on KIN-3248 at ASCO GI Cancers Symposium)
Analyst comments:
- EBS +5.7% (upgraded to Buy from Hold at The Benchmark Company)
- NVCR +3.7% (upgraded to Buy from Hold at Truist)
- ETSY +3.3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- AMRC +3.1% (upgraded to Outperform from Mkt Perform at Raymond James)